Q3 FY2026
Filed Nov 5, 2026Axon reports record Q3 2026 revenue of $909 million, up 28% year over year
Revenue, Software & Services growth, bookings and Adjusted EBITDA were strong, but the full-year revenue outlook was reduced following the removal of approximately $130 million of Federal Dedrone deployments, gross margins declined and free cash flow was an outflow.
Key metrics
shortened, hover for the filing’s print| Metric | Value | q/q | y/y |
|---|---|---|---|
| Q3 2026 net salesGAAP | $908.6M | – | 28% |
| Q3 2026 net sales from productsGAAP | $471.5M | – | – |
| Q3 2026 net sales from servicesGAAP | $437.0M | – | – |
| Q3 2026 gross marginGAAP | 56.7% | – | – |
| Q3 2026 adjusted gross marginnon-GAAP | 59.2% | – | – |
| Q3 2026 gross marginGAAP | $515.0M | – | – |
| Q3 2026 operating expensesGAAP | $472.9M | – | – |
| Q3 2026 selling, general and administrative expenseGAAP | $280.5M | – | – |
| Q3 2026 research and development expenseGAAP | $192.4M | – | – |
| Q3 2026 income from operationsGAAP | $42.08M | – | – |
| Q3 2026 net incomeGAAP | $57.01M | – | – |
| Q3 2026 net income marginGAAP | 6.3% | – | – |
| Q3 2026 diluted earnings per shareGAAP | $0.68 | – | – |
| Q3 2026 non-GAAP net incomenon-GAAP | $143.5M | – | – |
| Q3 2026 non-GAAP net income marginnon-GAAP | 15.8% | – | – |
| Q3 2026 non-GAAP diluted earnings per sharenon-GAAP | $1.72 | – | – |
| Q3 2026 Adjusted EBITDAnon-GAAP | $235.7M | – | 33% |
| Q3 2026 Adjusted EBITDA marginnon-GAAP | 25.9% | – | – |
| Q3 2026 operating cash flowGAAP | $19.69M | – | – |
| Q3 2026 free cash flownon-GAAP | −$18.90M | – | – |
| Q3 2026 capital expendituresGAAP | $38.59M | – | – |
| Q3 2026 annual recurring revenueother | $1.75B | – | 40% |
| Q3 2026 net revenue retentionother | 126% | – | – |
| Q3 2026 future contracted bookingsother | $15.8B | – | 39% |
| Nine months ended 30 SEP 2026 net salesGAAP | $2.62B | – | – |
| Nine months ended 30 SEP 2026 gross marginGAAP | $1.54B | – | – |
| Nine months ended 30 SEP 2026 income from operationsGAAP | $118.1M | – | – |
| Nine months ended 30 SEP 2026 net incomeGAAP | $255.7M | – | – |
| Nine months ended 30 SEP 2026 diluted earnings per shareGAAP | $3.08 | – | – |
| Nine months ended 30 SEP 2026 Adjusted EBITDAnon-GAAP | $679.3M | – | – |
| Nine months ended 30 SEP 2026 free cash flownon-GAAP | −$74.52M | – | – |
Segments
| Segment | Revenue | q/q | y/y |
|---|---|---|---|
| Software & ServicesGrowth in users and increasing adoption of premium solutions by existing customers, including AI, real-time operations, Axon Records and Axon 911. | $437.0M | 9.9% | 43.2% |
| Connected DevicesLed by Dedrone and continued adoption of Axon Body 4, partially offset by lower legacy TASER volume and the timing of an approximately $30 million Federal Dedrone deployment. | $471.5M | (6.9)% | 16.3% |
| TASERIncludes TASER devices, cartridges and related extended warranties. | $233.0M | – | – |
| Personal SensorsPrimarily includes body cameras and accessories, signal sidearm, and related extended warranties. | $113.5M | – | – |
| Platform SolutionsGrowth was led by Platform Solutions; the category primarily includes fleet in-car video, interview room, fixed cameras, drones and counter-drone equipment, virtual reality training hardware, and related extended warranties. | $125.0M | – | 106% |
Amounts quoted below without a unit are in thousands, as in the filing’s tables. Per-share figures are as printed.
Q4 2026 and full year 2026 outlook
- RevenueQ4 2026: $990 million to $1.01 billion; full year 2026: approximately $3.61 billion to $3.63 billion, representing approximately 30% annual growth
- NoteQ4 2026 Adjusted EBITDA: $245 million to $250 million
- NoteFull-year 2026 Adjusted EBITDA: $924 million to $929 million
- NoteFull-year 2026 Adjusted EBITDA margin: approximately 25.6%
- NoteFull-year 2026 free cash flow: $350 million to $400 million
- NoteFull-year 2026 stock-based compensation expense: approximately $570 million to $600 million
- Note2026 CapEx: $130 million to $150 million
- NoteInventory strategy expected to utilize $225 million in cash for the full year
What drove it
- Software & Services revenue grew 43% year over year, driven by growth in users and increasing adoption of premium solutions by existing customers.
- Newer software offerings, including real-time operations, Axon Records, Axon AI, Axon 911 and Dedrone software, collectively reached an annual revenue run rate of nearly $500 million.
- AI annual recurring revenue surpassed $100 million, and AI bookings were up over 50% year to date.
- Platform Solutions revenue increased 106% year over year to $125 million.
- New five-year bookings were up 25% year to date.
- Future contracted bookings grew 39% year over year to $15.8 billion.
- Axon announced an additional $1.2 billion investment in Skydio, increasing fully diluted ownership to 37%, alongside an exclusive public safety distribution partnership in the U.S. and Canada.
Concerns
- The full-year revenue outlook excludes approximately $130 million from three Federal Dedrone deployments no longer expected in 2026, including approximately $30 million previously expected in Q3 and $100 million previously expected in Q4.
- Total company gross margin declined to 56.7% from 60.1%, while adjusted gross margin declined to 59.2% from 62.7%, primarily due to counter-drone equipment mix, higher memory costs and scaling new product categories.
- Connected Devices gross margin declined to 43.0% from 49.9%; management cited increased counter-drone equipment mix and higher memory costs.
- Free cash flow was an outflow of $19 million, primarily reflecting approximately $100 million of strategic inventory investment.
- The company reported a net debt position of $1.2 billion as of September 30, 2026.
What to watch
- Timing and fulfillment of the three Federal Dedrone deployments totaling approximately $130 million excluded from the 2026 outlook.
- Whether Q4 revenue reaches the $990 million to $1.01 billion guidance range.
- Whether Software & Services maintains its 43% year-over-year growth rate and whether newer offerings continue to scale.
- Gross-margin effects from counter-drone equipment mix, memory costs and new product-category scaling.
- The pace at which the approximately $225 million full-year inventory investment moderates after the first quarter of 2027.
- Closing timing and financial impact of the $1.2 billion Skydio investment and ramp of Axon's exclusive distribution relationship.
Balance sheet and cash flow
- As of September 30, 2026, cash, cash equivalents and short-term investments were $1.7 billion.
- As of September 30, 2026, outstanding convertible and senior notes were $2.9 billion.
- As of September 30, 2026, Axon had a net debt position of $1.2 billion, up $182 million sequentially.
- Cash and cash equivalents were $1,458,817 (in thousands) at 30 SEP 2026, compared with $1,201,147 (in thousands) at 31 DEC 2025.
- Inventory was $579,225 (in thousands) at 30 SEP 2026, compared with $341,811 (in thousands) at 31 DEC 2025.
- Q3 operating cash flow was $19,687 (in thousands), including approximately $100 million of cash used for strategic inventory investment.
- Q3 free cash flow was an outflow of $19 million, compared to an inflow of $33 million in the prior-year period.
- Long-term notes payable, principal amount, were $(2,900,000) (in thousands) at 30 SEP 2026.
Analysis
Axon delivered record Q3 revenue of $909 million, up 28% year over year, with the revenue mix continuing to shift toward software. Software & Services grew 43% to $437 million, outpacing Connected Devices, which grew 16% to $472 million. Management attributed software growth to user growth and adoption of premium solutions, while newer offerings including AI, real-time operations, Axon Records, Axon 911 and Dedrone software collectively reached an annual revenue run rate of nearly $500 million. Annual recurring revenue rose 40% to $1.8 billion, net revenue retention was 126%, and future contracted bookings rose 39% to $15.8 billion.
Profitability improved substantially from the prior-year loss. GAAP operating income was $42 million versus a $2 million loss from operations, GAAP net income was $57 million versus a $2 million net loss, and Adjusted EBITDA increased 33% to $236 million. However, gross-margin pressure was material. Total gross margin declined to 56.7% from 60.1% and adjusted gross margin declined to 59.2% from 62.7%. Connected Devices was the principal pressure point, with gross margin falling to 43.0% from 49.9%, reflecting counter-drone equipment mix and higher memory costs. Software & Services gross margin also declined to 71.4% from 73.8% as new product offerings and professional services scaled.
Connected Devices revenue declined sequentially to $472 million from $507 million. Management identified normal third-quarter seasonality and the delayed timing of an approximately $30 million Federal Dedrone deployment as factors. Platform Solutions nevertheless grew 106% year over year to $125 million, while lower legacy TASER volume partially offset growth from Dedrone and Axon Body 4. The company also announced a $1.2 billion investment in Skydio that raises its fully diluted ownership stake to 37%, plus an exclusive U.S. and Canada public-safety distribution partnership. Skydio channel revenue will be recognized on a net basis in Software & Services.
Cash conversion was weak in the quarter because of inventory investment. Operating cash flow was $20 million, down from $60 million, and free cash flow was an outflow of $19 million versus an inflow of $33 million. The company said approximately $100 million of cash was used for strategic inventory investment during the quarter. Cash, cash equivalents and short-term investments were $1.7 billion, while convertible and senior notes were $2.9 billion, resulting in a net debt position of $1.2 billion.
The outlook was reduced because Axon no longer expects three large Federal Dedrone deployments totaling approximately $130 million to occur in 2026. Q4 revenue guidance is $990 million to $1.01 billion, implying full-year revenue of approximately $3.61 billion to $3.63 billion and approximately 30% growth, versus prior full-year growth guidance of 32% to 34%. Full-year Adjusted EBITDA guidance is $924 million to $929 million and the approximately 25.6% margin is 10 basis points above prior margin guidance of 25.5%. Full-year free-cash-flow guidance of $350 million to $400 million is below the prior $450 million target, while stock-based compensation and CapEx guidance were both reduced.
Not in the filing
stated, not guessed- Prior-release outlook was not provided; therefore, no actual-versus-prior-guidance comparisons are included.
- No share repurchases were reported.
- No dividends were reported.
- Q4 2026 gross margin guidance was not provided.
- Q4 2026 operating expense guidance was not provided.
- Q4 2026 tax rate guidance was not provided.
- No named company executive quote was provided in the filing text.
- Year-over-year and sequential percentage changes were not separately printed for all income-statement line items and product-category revenue lines.
Written by an AI language model from the company’s SEC earnings filing (Form 8-K Item 2.02, or Form 6-K for a foreign private issuer). Every figure is checked against the filing text, and a metric the filing does not print, or whose value, prior period and change do not add up, is dropped from the metrics. The model can still misread a table, in the metrics or in the text, so check a number in the filing before you rely on it. Consensus estimates, price targets and share-price reactions are not shown because they are not in the filing. AI-generated research, not investment advice.